The Institute for Management & Innovation (IMI) is pleased to invite you to the following IMI Seminar. Title:‟ An Introduction to Clinical Operations.” Guest Speaker: Dr. Peter Kalinka Tuesday, August 6, 2013, 6:30-7:30p.m. Room 110, Instructional Centre University of Toronto Mississauga Abstract: Clinical trials represent the costliest and the most time consuming elements within a drug development program. Looking at Clinical Operation gives an insight into the procedures and allows a glimpse into the world of Biotech and Pharma, Biosimilars and NCE’s. About the Speaker: Dr. Peter Kalinka is a Pioneer in the Biosimilars Arena, having been responsible for the development of Omnitrope, the very first Biosimilar to be approved in the EU, Australia and the US. He was then involved in the development of the second Biosimilar to be approved, Valtropin. This was followed by many other Biosimilars, Bio-betters and novel Biologics. In July of this year, Dr. Kalinka’s latest project, a biosimilar G-CSF, received positive opinion from the EMA. All welcome. Light refreshments will be served.
Posted on: Wed, 31 Jul 2013 17:19:58 +0000
Trending Topics
Recently Viewed Topics
© 2015